Ligand Pharmaceuticals IncorporatedLGNDNASDAQ
Loading
Cash Flow PerformanceCompressed
Percentile Rank29
3Y CAGR-49.9%
5Y CAGR-15.6%
Year-over-Year Change
Free cash flow yield
3Y CAGR
-49.9%/yr
vs +17.5%/yr prior
5Y CAGR
-15.6%/yr
Recent deceleration
Acceleration
-67.4pp
Decelerating
Percentile
P29
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 1.34% | -66.1% |
| 2024 | 3.95% | +1242.2% |
| 2023 | -0.35% | -103.2% |
| 2022 | 10.64% | +290.4% |
| 2021 | 2.73% | -12.4% |
| 2020 | 3.11% | +293.5% |
| 2019 | -1.61% | -128.8% |
| 2018 | 5.58% | +86.1% |
| 2017 | 3.00% | +83.1% |
| 2016 | 1.64% | - |